Novolog Insulin Shortage 2025. Pharmaceutical company novo nordisk (the sponsor) has advised us that it will gradually discontinue some of its earlier generation insulin products over the next 2 years. In an informal survey of 22 medicare plans, 10 plans are dropping at least one insulin from their formulary, according to diane omdahl, founder of 65 inc., which provides.
In some cases, novo nordisk, novolin r flexpens, and novolog 10 ml vials are on backorder with no refill date in sight. The company plans to cut the list price of its novolog insulin by 75%, and the prices for novolin and levemir by 65% starting in january 2025.